摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7'‑amino‑1,1′,2,2′,3′,4′‑hexahydro‑1′,3'‑dimethyl‑2,2′,4'‑trioxospiro[indole‑3,5'‑pyrano[2,3‑d]pyrimidine]‑6'‑carbonitrile

中文名称
——
中文别名
——
英文名称
7'‑amino‑1,1′,2,2′,3′,4′‑hexahydro‑1′,3'‑dimethyl‑2,2′,4'‑trioxospiro[indole‑3,5'‑pyrano[2,3‑d]pyrimidine]‑6'‑carbonitrile
英文别名
7′-amino-1′,3′-dimethyl-2,2′,4′-trioxo-1′,2′,3′,4′,4a′,8a′-tetrahydrospiro[indoline-3,5′-pyrano[2,3-d]pyrimidine]-6′-carbonitrile;7’-amino-1,1’,2,2’,3’,4’-hexahydro-1',3'-dimethyl-2,2',4’-trioxospiro[indole-3,5’-pyrano[2,3-d]pyrimidine]-6’-carbonitrile;spiro<1-methyloxindole-3,4'-(2'-amino-3'-cyano-6',8'-dimethyl-5',6',7',8'-tetrahydro-4'H-pyrano<2,3-d>pyrimidine-5',7'-dione)>;7'-amino-1',3'-dimethyl-2,2',4'-trioxo-1,1',2,2',3',4'-hexahydrospiro[indole-3,5'-pyrano[2,3-d]pyrimidine]-6'-carbonitrile;7'-amino-1,1',2,2',3',4'-hexahydro-1',3'-dimethyl-2,2',4'-trioxospiro[indole-3,5'-pyrano[2,3-d]pyrimidine]-6'-carbonitrile;7'-amino-1',3'-dimethyl-2,2',4'-trioxo-1',2',3',4'-tetrahydrospiro[indoline-3,5'-pyrano[2,3-d]pyrimidine]-6'-carbonitrile;7'-amino-1',3'-dimethyl-2,2',4'-trioxo-6'-spiro[1H-indole-3,5'-pyrano[2,3-d]pyrimidine]carbonitrile;7'-amino-1',3'-dimethyl-2,2',4'-trioxospiro[1H-indole-3,5'-pyrano[2,3-d]pyrimidine]-6'-carbonitrile
7'‑amino‑1,1′,2,2′,3′,4′‑hexahydro‑1′,3'‑dimethyl‑2,2′,4'‑trioxospiro[indole‑3,5'‑pyrano[2,3‑d]pyrimidine]‑6'‑carbonitrile化学式
CAS
——
化学式
C17H13N5O4
mdl
——
分子量
351.321
InChiKey
NWAXQIGOONAAQX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.4
  • 重原子数:
    26
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    129
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    1,3-二甲基巴比妥酸2-(1-Methyl-2-oxo-1,2-dihydro-indol-3-ylidene)-malononitrile哌啶 作用下, 以 乙醇 为溶剂, 反应 3.0h, 以93.6%的产率得到7'‑amino‑1,1′,2,2′,3′,4′‑hexahydro‑1′,3'‑dimethyl‑2,2′,4'‑trioxospiro[indole‑3,5'‑pyrano[2,3‑d]pyrimidine]‑6'‑carbonitrile
    参考文献:
    名称:
    Spiro heterocyclic compounds. III. Synthesis of spiro[oxindole-3,4'-(4'H-pyran)] compounds.
    摘要:
    Spiro[氧吲哚-3, 4'-(4'H-吡喃)]化合物(IIIa-j)是通过3-氰甲亚甲基氧吲哚(Ia, b)与活性亚甲基化合物的迈克尔反应制备的。同样,(Ib, c)与环状活性亚甲基化合物的反应,例如环己烷-1, 3-二酮、3-甲基-1-苯基-5-吡唑酮和巴比妥酸,得到了相应的含有缩合吡喃体系的螺旋化合物(V-VII)。
    DOI:
    10.1248/cpb.28.648
点击查看最新优质反应信息

文献信息

  • Synthesis of functionalized chromene and spirochromenes using l -proline-melamine as highly efficient and recyclable homogeneous catalyst at room temperature
    作者:Sakkani Nagaraju、Banoth Paplal、Kota Sathish、Santanab Giri、Dhurke Kashinath
    DOI:10.1016/j.tetlet.2017.09.060
    日期:2017.11
    commercially cheap l-proline and melamine for the synthesis of chromenes and spirochromenes (spirooxindoles) via multicomponent reactions at room temperature. Systematic studies were conducted in order to achieve desired reactivity and recyclability of the catalyst using various α-amino acids and aromatic amines as donor-acceptor pairs. Among the screened combinations, l-proline and melamine (3:1 ratio;
    使用便宜的1-脯酸和三聚氰胺开发了一种有效且可循环使用的均相催化剂,用于在室温下通过多组分反应合成色和螺环色酮(螺并辛多)。为了使用各种α-氨基酸和芳族胺作为供体-受体对,进行系统研究以实现所需的反应性和催化剂的可回收性。在筛选的组合中,l脯酸和三聚氰胺(3:1的比例;占总重量的3 mol%)被认为是最佳的催化剂,可以在室温下非常短的时间内(1-15分钟)以优异的产率(高达99%)提供所需的产品在DMSO中作为溶剂。通过添加EtOAc来回收催化剂,并且在不损失催化活性的情况下重复使用多达5个循环。
  • Nano-FGT: a green and sustainable catalyst for the synthesis of spirooxindoles in aqueous medium
    作者:Ramen Jamatia、Ajay Gupta、Amarta Kumar Pal
    DOI:10.1039/c5ra27552k
    日期:——
    glutathione grafted nano-organocatalyst (nano-FGT) was used as an efficient catalyst for the synthesis of spirooxindole derivatives. An aqueous medium, easy separation by an external magnet, efficient catalyst reusability, low catalyst loading, and column chromatography free separation of the product makes the present procedure green, sustainable and economically viable. The TON and TOF of the nanocatalyst
    谷胱甘肽接枝的纳米有机催化剂(nano-FGT)被用作合成螺恶英吲哚生物的有效催化剂性介质,易于被外部磁体分离,有效的催化剂重复使用性,低的催化剂负载量以及产物的无柱色谱分离使本发明方法绿色,可持续且经济可行。纳米催化剂的TON和TOF分别达到850 000和56 667 min -1。
  • Na2EDTA: an efficient, green and reusable catalyst for the synthesis of biologically important spirooxindoles, spiroacenaphthylenes and spiro-2-amino-4H-pyrans under solvent-free conditions
    作者:Tayebeh Jazinizadeh、Malek Taher Maghsoodlou、Reza Heydari、Afshin Yazdani-Elah-Abadi
    DOI:10.1007/s13738-017-1148-3
    日期:2017.10
    For the first time, the organic salt Na2EDTA was used as a catalyst for an effective and facile preparation of spiro-4H-pyrans via single-pot three-component condensation of isatin/acenaphthoquinone/ninhydrin, malononitrile, and CH-acids through Knoevenagel–Michael–annulation sequence. This new protocol employing Na2EDTA, which is a green, recyclable, and inexpensive catalyst, offers advantages such
    第一次,将有机盐Na 2 EDTA用作催化剂,通过Isatin / ac醌/丙二腈和CH-酸的单锅三组分缩合反应,有效而便捷地制备spiro-4 H -pyrans通过Knoevenagel–Michael–环形序列。这项采用Na 2 EDTA的新方案是一种绿色,可回收且廉价的催化剂,具有无溶剂,高效反应条件,反应时间短(10-15分钟),后处理容易,收率高等优点。比其他环境合成方法更经济。
  • A green and sustainable approach for the synthesis of 1,5-benzodiazepines and spirooxindoles in one-pot using a MIL-101(Cr) metal–organic framework as a reusable catalyst
    作者:Fillip Kumar Sarkar、Ajay Gupta、Ramen Jamatia、Jasha Momo H. Anal、Amarta Kumar Pal
    DOI:10.1039/d1nj03176g
    日期:——
    MIL-101(Cr) has been efficiently utilized for the synthesis of biologically relevant heterocycles such as 1,5-benzodiazepines and spirooxindoles in one-pot. MIL-101(Cr) was prepared via a solvothermal method and characterized by FT-IR, PXRD, SEM, TEM, EDX, and ICP-OES analysis. Thermogravimetric analysis (TGA) described its high thermal stability. Low catalyst loading, easy separation, reusability, and high
    属-有机骨架 MIL-101(Cr) 已被有效地用于合成生物相关的杂环,如 1,5-卓类和螺环吲哚。MIL-101(Cr) 是通过溶剂热法制备的,并通过 FT-IR、PXRD、SEM、TEM、EDX 和 ICP-OES 分析进行表征。热重分析 (TGA) 描述了其高热稳定性。低催化剂负载、易于分离、可重复使用和高产率是该协议的一些显着特点。无溶剂反应条件 (SFRC) 或作为溶剂是绿色和可持续工艺开发领域的一些额外优势。
  • A convenient route toward one‐pot multicomponent synthesis of spirochromenes and pyranopyrazoles accelerated via quinolinic acid
    作者:Maryam Oudi、Kazem Sanchooli Tazeh、Nourallah Hazeri、Maryam Fatahpour、Raheleh Ahmadi
    DOI:10.1002/jccs.201800470
    日期:2019.12
    quinolinic acid (QUIN) was studied for the synthesis of spirochromene and pyranopyrazole derivatives from readily available materials. The salient features of these one‐pot multicomponent protocols are the clean reaction profile, easy isolation of products, no chromatographic separation techniques, high efficiency, short reaction time, and high yield of products plus using QUIN as a new, inexpensive, commercially
    在当前的工作中,研究了喹啉酸(QUIN)的催化活性,用于从容易获得的材料合成螺环戊二烯喃并吡唑生物。这些一锅法多组分方案的显着特征是反应曲线干净,产物易于分离,无需色谱分离技术,效率高,反应时间短,产物收率高,再加上将QUIN用作一种新型,廉价,可商购的产品,高效的有机催化剂
查看更多

同类化合物

叔-丁基2-(甲磺酰)-5,7-二氢螺[吡喃并[4,3-D]嘧啶并-8,3-吡咯烷]-1-甲酸基酯 乙基7'-氨基-6-氟-2,2',4'-三羰基-1,1',2,2',3',4'-六氢螺[吲哚-3,5'-吡喃并[2,3-d]嘧啶]-6'-羧酸酯 7H-吡喃并[2,3-d]嘧啶-7-酮 7H-吡喃并[2,3-d]嘧啶 7,8-二氢-5H-吡喃并[4,3-D]嘧啶-2-胺 5H-吡喃并[4,3-d]嘧啶 5H-吡喃并[2,3-d]嘧啶 2H-吡喃并[2,3-d]嘧啶-6-甲腈,7-氨基-1,3,4,5-四氢-5-(4-甲氧苯基)-2,4-二羰基- 2,4-二氯-7,8-二氢-5H-吡喃[4,3-d]嘧啶 1H-吡喃并[3,4-d]嘧啶 1H-吡喃并[3,2-d]嘧啶 (5S,7R,8S)-2-methylsulfanyl-5,8-dihydro-7-allyloxymethyl-5-methoxy-pyrano[3,4-d]-pyrimidin-8-ol 5-ethyl-2-[(Z)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-ethyl-2-[[1-(3-methylbutanoyl)piperidin-4-ylidene]amino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-butyl-2-[(E)-1-(4-cyclohexylpiperazin-1-yl)butylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 2,3,3a,9-tetrahydro-5-iodo-2,3,3-trimethylimidazo[5,1-b][1,3]benzoxazin-1-one 2,4-dimethyl-9-methoxy-4,12b-dihydro-1H,7H-chromeno[4',3'-4,5]pyrano[2,3-d]pyrimidine-1,3(2H)-dione 5-methyl-3-{3-[(R)-2-oxo-3-(3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)-oxazolidin-5-yl]-propyl}-1H-quinazoline-2,4-dione 7-amino-2-(benzothiazol-2-ylmethyl)-9-phenylthiazolo[4',5':6,5]pyrano[2,3-d]pyrimidine-8(7H)-one 2-[6-[(2-chlorophenyl)methyl]pyridin-2-yl]-7,8-dihydro-5H-pyrano[4,3-d]pyrimidine 8-amino-2-(methylthio)-5-oxo-6-(pyridin-4-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 5-(4-chlorophenyl)-1,3,8,8-tetramethyl-7,9-dihydro-5H-chromeno[2,3-d]pyrimidine-2,4,6-trione ethyl 7'-amino-2,4'-dioxo-2'-thioxo-1,1',2,2',3',4'-hexahydrospiroindole-3,5'-pyrano[2,3-d]pyrimidine-6'-carboxylate 8-amino-2-(methylthio)-5-oxo-6-(pyridin-3-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 7-Amino-4-oxo-5-phenyl-2-thioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylic acid ethyl ester 3-(1H-benzoimidazol-2-yl)-3-butyl-5-methyl-dihydro-furan-2-one 3-(1H-benzoimidazol-2-yl)-3-(2-diethylamino-ethyl)-5-methyl-dihydro-furan-2-one 1-{4-[(1R,9S)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea (S)-6-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyridin-2(1H)-one 3-(1H-benzoimidazol-2-yl)-5-methyl-3-(3-methyl-butyl)-dihydro-furan-2-one 13-(3,4-dimethoxyphenyl)-5,5-dimethyl-2-thioxo-2,5,6,8,9,13-hexahydro-4H-pyrimido[5',4':6,7][1,8]naphthyridino[4,3,2-de]quinazoline-10,12(3a1H,11H)-dione (S)-3-allyl-8-ethyl-4,7-dioxo-2-(phenylcarbamoyl)-4,5,7,8-tetrahydro-3H-pyrano[4,3-d]pyrimidin-8-yl acetate 8-{[(2-bromo-3-methylphenyl)oxy]methyl}-1,3-dimethyl-2,3,4,6-tetrahydro-1H-pyrano[3,2-d]pyrimidine-2,4-dione 9-ethyl-6a-methyl-2-phenyl-8,9-dihydro-oxazolo[2,3-b]pyrimido[4,5-d][1,3]oxazin-5-one (S)-1-cyclobutyl-3-(4-(4-(3-methylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenyl)urea (S)-2-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyrimidin-4(3H)-one (6aRS,10aRS)-4,6,6a,7,8,9,10,10a-octahydro-2,4,6,6-tetramethyl-1H-<2>benzopyrano<3,4-d>pyrimidine-1,3(2H)-dione 5-ethyl-2-[(E)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione N3-(methyl 4-deoxy-α-L-threo-hex-4-enopyranosyluronate)-5-fluorouracil 1-{4-[(1S,9R)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea 4,5-dimethyl-12-(4-methoxyphenyl)-2-thioxo-2,4a,7,8,9,10,11,12-octahydrodipyrimido[4,5-b;4',5'-f] [1,8]naphthyridine-9,11-dione 2-[4-[2-hydroxyethyl(methyl)amino]-2-methyl-7-oxopyrimido[5,4-b][1,4]oxazin-8-yl]acetonitrile 5-ethyl-2-[(Z)-1-thiophen-2-ylethylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione